Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hilotherm manufactures medical cooling therapy devices that have shown effectiveness in preventing chemotherapy-induced polyneuropathy (CIPN) and hand-foot syndrome (HFS). Studies show that without prophylactic HILOTHERAPY®, 90% of patients develop symptoms of CIPN and Hand-Foot-Syndrome, with 50% experiencing severe symptoms (Grade 2/3)[3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hilotherm GmbH.